Plasma Drug Concentration Time Profile
Pharmacokinetic Parameter
Pharmacodynamic Parameter
Zero, First Order & Mixed Order Kinetic
Rates & Order Of Kinetics
Pharmacokinetic Models
Application Of Pharmacokinetic
Plasma Drug Concentration Time Profile
Pharmacokinetic Parameter
Pharmacodynamic Parameter
Zero, First Order & Mixed Order Kinetic
Rates & Order Of Kinetics
Pharmacokinetic Models
Application Of Pharmacokinetic
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
Methods for Measurement of bioavailability pharmacampus
Which are the Methods for Measurement of bioavailability?- Pharmacokinetic method- Plasma level time studies, Urinary excretion studies.
Pharmacodynamic method: Acute pharmacologic response, Therapeutic response.
Methods For Assesment Of Bioavailability Anindya Jana
Bioavailability means the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
Bioavailability studies are important in the Primary stages of development of a suitable dosage form for a new drug entity, determination of influence of excipients, patient related factors & possible interaction with other drugs on the efficiency of absorption, development of new formulations of the existing drugs, control of quality of a drug product during the early stages of marketing in order to determine the influence of processing factors, storage & stability on drug absorption
Transdermal Drug Delivery System (TDDS) is the one of the novel technology to deliver the molecules through the skin for long period of time.
Transdermal Drug Delivery System (TDDS) are defined as self contained, discrete dosage forms which are also known as “patches” 2, 3 when patches are applied to the intact skin, deliver the drug through the skin at a controlled rate to the systemic circulation
It is defined as “the predictive mathematical model that describes the relationship between in vitro property (such as rate & extent of dissolution) of a dosage form and in vivo response (such as plasma drug concentration or amount of drug absorbed)”.
Methods for Measurement of bioavailability pharmacampus
Which are the Methods for Measurement of bioavailability?- Pharmacokinetic method- Plasma level time studies, Urinary excretion studies.
Pharmacodynamic method: Acute pharmacologic response, Therapeutic response.
Methods For Assesment Of Bioavailability Anindya Jana
Bioavailability means the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
Bioavailability studies are important in the Primary stages of development of a suitable dosage form for a new drug entity, determination of influence of excipients, patient related factors & possible interaction with other drugs on the efficiency of absorption, development of new formulations of the existing drugs, control of quality of a drug product during the early stages of marketing in order to determine the influence of processing factors, storage & stability on drug absorption
Transdermal Drug Delivery System (TDDS) is the one of the novel technology to deliver the molecules through the skin for long period of time.
Transdermal Drug Delivery System (TDDS) are defined as self contained, discrete dosage forms which are also known as “patches” 2, 3 when patches are applied to the intact skin, deliver the drug through the skin at a controlled rate to the systemic circulation
Drug Absorption ,m.pharm, semester 2, 1st yearManshiRana2
Drug absorption is the process of movement of unchanged drug from the site of administration to systemic circulation.
Absorption is the process of movement of unchanged drug from the site of administration to the site of measurement i.e. Plasma.
The amount of drug that enters the body from site of administration to the systemic circulation is known as absorption. The rate of absorption affects the onset, duration and intensity of drug action.
Absorption involves several phases. First, the drug needs to be introduced via some route of administration and in a specific dosage form such as a tablet, capsule, and so on.
Absorption is a primary focus in drug development and medicinal chemistry, since the drug must be absorbed before any pharmacological effects can take place.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
2. CONTENTS
Introduction of absorption.
Structure of the Cell Membrane.
Mechanism of Drug absorption.
Conclusion
References
2
3. Introduction of Absorption1,3,4,5
Definition :
The process of movement of unchanged
drug from the site of administration to systemic
circulation.
There always exist a correlation between the plasma
concentration of a drug & the therapeutic response &
thus, absorption can also be defined as the process of
movement of unchanged drug from the site of
administration to the site of measurement.
i.e., plasma.
3
4. Minimum effective conc.
Therapeutic success of a
rapidly & completely
absorbed drug.
Therapeutic failure of a
slowly absorbed drug.
Subtherapeutic level
Time
Plasma
Drug
Conc.
Not only the
magnitude of drug
that comes into the
systemic circulation
but also the rate at
which it is absorbed
is important this is
clear from the figure.
4
6. MECHANISM OF DRUG
ABSORPTION1,2,3,4,5
1) Passive diffusion
2) Pore transport
3) Carrier- mediated transport
a) Facilitated diffusion
b) Active transport
4) Ionic or Electrochemical diffusion
5) Ion-pair transport
6) Endocytosis
6
7. 7
1) Passive Diffusion1,2,3,4,5,6
Also known as non-ionic
diffusion.
It is defined as the
difference in the drug
concentration on either
side of the membrane.
Absorption of 90% of
drugs.
The driving force for this
process is the
concentration or
electrochemical gradient.
8. 8
Passive diffusion is best expressed by
Fick’s first law of diffusion which states
that the drug molecules diffuse from a
region of higher concentration to one of
lower concentration until equilibrium is
attained & the rate of diffusion is directly
proportional to the concentration
gradient across the membrane.
dQ = D A Km/w (CGIT – C)
dt h
11. 11
1. Downhill transport.
2. Greater the surface area & lesser the thickness of the
membrane, faster the diffusion.
3. Equilibrium is attained when the concentration on either side
of the membrane become equal.
4. Greater the membrane/ water partition coefficient of drug,
faster the absorption.
5. The unionized species are 3-4 times more faster transported
6. It is energy dependent and nonsaturable
Certain characteristic of passive diffusion can
be generalized.
12. 2) Pore transport1,2,5
It is convective transport, bulk
flow or filtration.
Important in the absorption of
low mol. wt., low mol. size &
generally water-soluble drugs
e.g. urea, water & sugars.
The driving force for the passage
of the drugs is the hydrostatic or
the osmotic pressure
12
14. 3) Carrier Mediated System1,2,3,4,5
Involves a carrier which binds reversibly with the
solute molecules to be transported to yield the
carrier solute complex which transverses across the
membrane to the other side where it dissociates to
yield the solute molecule
The carrier then returns to its original site to accept
a fresh molecule of solute.
There are two types of carrier mediated transport
system:
a) facilitated diffusion
b) active transport
14
18. 18
a) Facilitated Diffusion1,2,3,4,6
This mechanism involves
the driving force is
concentration gradient.
In this system, no
expenditure of energy is
involved (down-hill
transport), therefore the
process is not inhibited
by metabolic poisons
that interfere with energy
production.
19. 19
Limited importance in the absorption of drugs.
e.g. Such a transport system include entry of
glucose into RBCs & intestinal absorption of
vitamins B1 & B2.
A classical example of passive facilitated diffusion
is the gastro-intestinal absorption of vitamin B12.
An intrinsic factor (IF), a glycoprotein produced by
the gastric parietal cells, forms a complex with
vitamin B12 which is then transported across the
intestinal membrane by a carrier system.
20. 20
b) Active transport1,2,3,4,5,6
More important process
than facilitated diffusion.
The driving force is against
the concentration gradient
or uphill transport.
Since the process is uphill,
energy is required in the
work done by the barrier.
As the process requires
expenditure of energy, it can
be inhibited by metabolic
poisons that interfere with
energy production.
24. 24
The rate of absorption by active transport can be
determined by applying the equation used for
Michalies-menten kinetics:
dc = [C].(dc/dt)max
dt Km + [C]
Where,
(dc/dt)max = maximal rate of drug
absorption at high drug concentration.
[C] = concentration of drug available
for absorption
Km = affinity constant of drug for the
barrier.
25. 4) Ionic or electrochemical diffusion1,4
The charge on
membrane
influences the
permeation of
drugs.
25
Gastrointestinal
lumen
Unionized form
Membrane
Rapid absorbed
Blood
Moderate absorbed-
Anion
+
Cation with high K.E
-
+Slowly absorbed
26. 26
Once inside the membrane, the cations are
attached to negatively charged intracellular
membrane, thus giving rise to an electrical
gradient.
If the same drug is moving from a higher to lower
concentration, i.e., moving down the electrical
gradient , the phenomenon is known as
electrochemical diffusion.
Molecular forms of solutes are unaffected by the
membrane charge & permeate faster than cationic forms.
Thus, at a given pH, the rate of permeation may be as
follows:
Unionized molecule > anions > cations
28. 28
5) Ion pair transport1,4,5
It is another
mechanism is
able to explain
the absorption
of such drugs
which ionize at
all pH
condition.
Gastrointestinal
lumen
Cationic
drug
Endogenus
anion
Neutral ion pair
complex
Membrane Blood
Free
drug
Dissociation
of complex
Passive
Diffusion
29. 29
Transport of charged molecules due to the
formation of a neutral complex with another
charged molecule carrying an opposite charge.
Drugs have low o/w partition coefficient values, yet
these penetrate the membrane by forming
reversible neutral complexes with endogenous
ions.
e.g. mucin of GIT.
Such neutral complexes have both the required
lipophilicity as well as aqueous solubility for
passive diffusion.
E.g. propranol
30. 6) Endocytosis1,2,4,5
It involves engulfing extracellular materials within a segment of the cell
membrane to form a saccule or a vesicle (hence also called as
corpuscular or vesicular transport) which is then pinched off
intracellular.
Sometimes ,an endocytotic vesicle is transferred from one compartment
to another. Such phenomenon is called transcytosis.
Endocytosis includes two types of processes
30
1. Phagocytosis
2. pinocytosis
31. 31
A) Phagocytosis1,2,4,7
This process involves
the absorptive uptake of
solid particulates,
macromolecules.
It is also called as cell
eating.
36. Conclusion
36
Drugs which are hydrophobic, MW in range 100-
400 absorbed passively.
Hydrophilic & MW less than 100 absorbed by
pore transport.
Drugs ionizes at all pH conditions absorbed after
complexing with oppositely charged ions through ion
pair transport.
Structure specific drugs with affinity for carriers
transported from specific sites most absorbed by
carrier mediated transport
Macromolecular nutrients & drugs as solid
particles or oily droplets absorbed by Endocytosis.
37. REFERENCES
1. D.M.Brahmankar & Sunil B. Jaiswal, Biopharmaceutics &
pharmacokinetics 2nd ed., vallabh prakashan pg no.5-23
2. Gerard J. Tortora Bryan H. Derrickson, Principles of Anatomy &
Physiology, 12th edition, vol.1st John Wiley & Sons,Inc. ,pg no.63, 77
3. Milo Gibaldi ,Biopharmaceutics & clinical pharmacokinetics 4th
edition, pg no.24-27
4. J.S. Kulkarni, A.P Pawar, V.P. Shedbalkar Biopharmaceutics &
pharmacokinetics, 1st ed., CBS publishers pg no.1-12
5. H. P. Tipnis & Amrita Bajaj, Principles & Applications of
Biopharmaceutics & Pharmacokinetics 1st ed., Career publication pg
no.19-23
6. http://www.pharmacology2000.com
7. http://www.inpharm.com
37